SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

補聴器市場

出版：MarketsandMarkets

Hearing Aids Market by Product Type [Aids (Receiver,Behind the Ear, In the Canal, In the Ear Aids), Implants (Cochlear, Bone-anchored)], Type of Hearing Loss (Sensorineural, Conductive), Patient Type (Adults, Pediatrics), Region – Global Forecast to 2026
種別英文調査報告書
出版MarketsandMarkets
出版年月2021年 7月
ページ数230
図表数294
–
レポート目次 お問合せ
– 補聴器市場の[補聴器（レシーバー、耳の後ろ、外耳道、耳のエイド）、インプラント（蝸牛、骨固定）]、難聴のタイプ（感音難聴、伝導性）、患者のタイプ（成人、小児科）、地域-2026年までの世界予測The global hearing aids market is projected to reach USD 10.2 billion by 2026 from USD 7.5billion in 2021, at a CAGR of 6.4% during the forecast period. Market growth is driven by factors such as the increasing adoption of smart hearing aids due to the rising incidence of noise-induced hearing loss, the growing prevalence of hearing loss, and technological advancements in hearing aids. On the other hand, the high cost of hearing aids and the requirement of high capital investments are the major factors hampering the growth of this market.“The hearing implantssegment accounted for the highest growth rate in thehearing aidsmarket, by product, during the forecast period”The hearing aids market is segmented into hearing aid devices and hearing implants based on product. In 2020, the hearing implants segment accounted for the highest growth rate in the hearing aids market.The high incidence of hearing disorders, technological advancements in hearing implants, and growth in the geriatric population are the major factors contributing to the growth of this segment. However, the high cost of these implants and the low awareness about hearing implants in emerging countries are some of the major factors that are hindering the growth of this market segment. “Sensorineural hearing loss segment accounted for the highest CAGR”Based on the type of hearing loss, the hearing aids market is segmented into sensorineural hearing loss and conductive hearing loss. In 2020, the sensorineural hearing loss segment accounted for the highest growth rate. This can be attributed to thehigh prevalence of sensorineural hearing loss, coupled with the growing geriatric patient pool.“Asia Pacific: The fastest-growing regionhearing aids market”The global hearing aids market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period.Factors such as the increasing prevalence of hearing loss, increasing healthcare spending, growing per capita income, and the presence of several high-growth marketsare driving the growth of the hearing aids market in this region. The low labor costs and the favorable regulatory environment in this region are also expected to propel the market growth.The primary interviews conducted for this report can be categorized as follows:•By Company Type: Tier 1 – 40%, Tier 2 – 30%,and Tier 3 -30%•By Designation: C-level – 27%, D-level – 18%, and Others – 55%•By Region: North America -51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and the Middle East & Africa – 4%Lists of Companies Profiled in the Report:•Sonova Group (Switzerland)•Demant A/S (Denmark)•GN Store Nord A/S (Denmark)•Cochlear Ltd. (Australia)•RION Co., Ltd. (Japan)•Starkey (US)•Nurotron Biotechnology Co., Ltd. (China)•MED-EL (Austria)•Audina Hearing Instruments, Inc. (US)•ElkonPvt. Ltd. (India)•WS Audiology A/S (Denmark)•Eargo, Inc. (US)•Horentek (Italy)•ZOUNDS Hearing Inc. (US)•SeboTek Hearing Systems, LLC. (US)•Arphi Electronics Private Limited (India)•IN4 Technology Corporation (China)•BHM-Tech ProduktionsgesellschaftmbH (Austria)•Nano Hearing Aids (US)•LORECas.r.o. (Turkey)•Earlens Corporation (US)•Austar Hearing Science and Technology (Xiamen) Co., Ltd. (China)•Lively Hearing Corporation (US)•audifon GmbH & Co. KG (Germany)•Foshan Vohom Technology Co., Ltd. (China)Research Coverage:This report provides a detailed picture of the global hearing aidsmarket. It aims at estimating the size and future growth potential of the market across different segments, such as product, type of hearing loss, patient type,and region. The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.Key Benefits of Buying the Report:The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall hearing aids market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

目次

1INTRODUCTION321.1OBJECTIVES OF THE STUDY321.2MARKET DEFINITION321.2.1INCLUSIONS & EXCLUSIONS OF THE STUDY321.2.2MARKETS COVERED33FIGURE 1HEARING AIDS MARKET SEGMENTATION331.2.3YEARS CONSIDERED FOR THE STUDY331.3CURRENCY341.4LIMITATIONS341.5STAKEHOLDERS341.6SUMMARY OF CHANGES342RESEARCH METHODOLOGY362.1RESEARCH DATA362.2RESEARCH APPROACH36FIGURE 2HEARING AIDS MARKET: RESEARCH DESIGN362.2.1SECONDARY DATA362.2.1.1Key data from secondary sources372.2.2PRIMARY DATA382.2.2.1Primary sources382.2.2.2Key data from primary sources392.2.2.3Key industry insights392.2.2.4Breakdown of primary interviews40FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (HEARING AIDS MARKET)40FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION402.3MARKET SIZE ESTIMATION402.3.1BOTTOM-UP APPROACH412.3.1.1Approach 1: Company revenue estimation approach41FIGURE 5BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH412.3.1.2Approach 2: Market estimation from the parent market41FIGURE 6BOTTOM-UP APPROACH: MARKET ESTIMATION FROM THE PARENT MARKET412.3.1.3Approach 3: Presentations of companies and primary interviews422.3.1.4Growth rate assumptions422.3.1.5CAGR projections42FIGURE 7CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS42 2.3.2TOP-DOWN APPROACH43FIGURE 8HEARING AIDS MARKET: TOP-DOWN APPROACH432.4MARKET BREAKDOWN & DATA TRIANGULATION44FIGURE 9DATA TRIANGULATION METHODOLOGY442.5ASSUMPTIONS FOR THE STUDY452.6LIMITATIONS452.7RISK ASSESSMENT46TABLE 1RISKS ASSESSMENT462.8COVID-19 HEALTH ASSESSMENT462.9COVID-19 ECONOMIC ASSESSMENT46FIGURE 10RECOVERY SCENARIO OF THE GLOBAL ECONOMY472.10ASSESSMENT OF THE IMPACT OF COVID-19 ON THE HEARING AIDS MARKET483EXECUTIVE SUMMARY49FIGURE 11HEARING AIDS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)49FIGURE 12HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2021 VS. 2026 (USD MILLION)50FIGURE 13HEARING AIDS MARKET, BY PATIENT TYPE, 2021 VS. 2026 (USD MILLION)50FIGURE 14HEARING AIDS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)514PREMIUM INSIGHTS524.1HEARING AIDS MARKET OVERVIEW52FIGURE 15RISING PREVALENCE OF HEARING LOSS TO DRIVE THE MARKET GROWTH524.2HEARING AIDS MARKET SHARE, BY PRODUCT, 2021 VS. 202652FIGURE 16HEARING AID DEVICES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026524.3HEARING AIDS MARKET SHARE, BY TYPE OF HEARING LOSS, 2021 VS. 202653FIGURE 17SENSORINEURAL HEARING LOSS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD534.4HEARING AIDS MARKET SHARE, BY PATIENT TYPE, 2021 VS. 202653FIGURE 18ADULT PATIENTS SEGMENT TO CONTINUE TO DOMINATE THE MARKET IN 2026534.5HEARING AIDS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES54FIGURE 19ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE HEARING AIDS MARKET DURING THE FORECAST PERIOD545MARKET OVERVIEW555.1INTRODUCTION555.2MARKET DYNAMICS55FIGURE 20HEARING AIDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES555.2.1DRIVERS555.2.1.1Growing prevalence of hearing loss55FIGURE 21ESTIMATED NUMBER OF PEOPLE WITH DISABLING HEARING LOSS, GLOBALLY56FIGURE 22PREVALENCE OF HEARING LOSS, BY REGION, 2019565.2.1.1.1Growth in the geriatric population57FIGURE 23SHARE OF THE GLOBAL POPULATION AGED 65 AND ABOVE (2015–2019)575.2.1.2Technological advancements in hearing aids575.2.1.3Increasing adoption of smart hearing aids due to the rising incidence of noise-induced hearing loss585.2.2RESTRAINTS585.2.2.1High cost of hearing aids585.2.3OPPORTUNITIES595.2.3.1Emerging markets offer lucrative opportunities595.2.4CHALLENGES595.2.4.1Shortage of trained professionals595.3EPIDEMIOLOGY DATA ON HEARING LOSS AND THE ADOPTION OF HEARING AID DEVICES60TABLE 2GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020, BY AGE GROUP60TABLE 3GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020, BY AGE GROUP (10-YEAR RANGE)60TABLE 4GLOBAL NUMBER OF PEOPLE USING HEARING AID DEVICES, BY AGE GROUP615.4IMPACT OF COVID-19 ON THE HEARING AIDS MARKET615.5CASE STUDY ANALYSIS625.5.1CASE STUDY 1: FINDING A NEW WAY TO LISTEN TO CUSTOMERS625.5.2CASE STUDY 2: EFFECTIVE SERVICE DELIVERY MODELS AND REGULATIONS CAN IMPROVE ACCESS TO HEARING AIDS625.5.3CASE STUDY 3: OVER-THE-COUNTER HEARING AID DELIVERY CAN IMPROVE ACCESSIBILITY AND AFFORDABILITY635.6PESSIMISTIC AND OPTIMISTIC SCENARIOS635.6.1HEARING AIDS MARKET63FIGURE 24PESSIMISTIC SCENARIO63FIGURE 25OPTIMISTIC SCENARIO645.7PRICING ANALYSIS64TABLE 5PRICE OF HEARING AIDS (2021)645.8PATENT ANALYSIS655.8.1PATENT ANALYSIS OF COCHLEAR IMPLANTS655.9TRADE ANALYSIS655.9.1TRADE ANALYSIS FOR HEARING AIDS65TABLE 6IMPORT DATA FOR HEARING AIDS, BY COUNTRY, 2016–2020 (USD MILLION)65TABLE 7EXPORT DATA FOR HEARING AIDS, BY COUNTRY, 2016–2020 (USD MILLION)665.10VALUE CHAIN ANALYSIS66FIGURE 26MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE665.10.1HEARING AID DEVICES VALUE CHAIN IN THE PRIVATE SECTOR67TABLE 8HEARING AID DEVICES VALUE CHAIN IN THE PRIVATE SECTOR675.11SUPPLY CHAIN ANALYSIS67FIGURE 27HEARING AIDS MARKET: SUPPLY CHAIN ANALYSIS685.12ECOSYSTEM ANALYSIS OF THE HEARING AIDS MARKET69FIGURE 28HEARING AIDS MARKET: ECOSYSTEM ANALYSIS695.12.1ROLE IN ECOSYSTEM695.13PORTER’S FIVE FORCES ANALYSIS70TABLE 9HEARING AIDS MARKET: PORTER’S FIVE FORCES ANALYSIS705.13.1THREAT OF NEW ENTRANTS705.13.2THREAT OF SUBSTITUTES705.13.3BARGAINING POWER OF BUYERS705.13.4BARGAINING POWER OF SUPPLIERS705.13.5DEGREE OF COMPETITION715.14REGULATORY LANDSCAPE715.14.1NORTH AMERICA715.14.1.1US715.14.1.2Canada715.14.2EUROPE715.14.3ASIA PACIFIC715.14.3.1Japan715.14.3.2India725.14.4LATIN AMERICA725.14.4.1Brazil725.14.4.2Mexico725.14.5MIDDLE EAST725.15TECHNOLOGY ANALYSIS735.16TRENDS/DISRUPTIONS IMPACTING THE BUSINESS OF CUSTOMERS745.16.1REVENUE SOURCES ARE SHIFTING TOWARD MORE TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC745.16.2REVENUE SHIFT FOR THE HEARING AIDS MARKET746HEARING AIDS MARKET, BY PRODUCT756.1INTRODUCTION76TABLE 10HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)76TABLE 11HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)766.2HEARING AID DEVICES76TABLE 12KEY PRODUCTS IN THE HEARING AID DEVICES MARKET77TABLE 13HEARING AID DEVICES MARKET, BY REGION, 2016–2019 (USD MILLION)78TABLE 14HEARING AID DEVICES MARKET, BY REGION, 2020–2026 (USD MILLION)78TABLE 15HEARING AID DEVICES MARKET, BY REGION, 2016–2019 (MILLION UNITS)79TABLE 16HEARING AID DEVICES MARKET, BY REGION, 2020–2026 (MILLION UNITS)79TABLE 17NORTH AMERICA: HEARING AID DEVICES MARKET, BY COUNTRY, 2016–2019 (MILLION UNITS)80TABLE 18NORTH AMERICA: HEARING AID DEVICES MARKET, BY COUNTRY, 2020–2026 (MILLION UNITS)80TABLE 19EUROPE: HEARING AID DEVICES MARKET, BY COUNTRY, 2016–2019 (MILLION UNITS)80TABLE 20EUROPE: HEARING AID DEVICES MARKET, BY COUNTRY, 2020–2026 (MILLION UNITS)81TABLE 21APAC: HEARING AID DEVICES MARKET, BY COUNTRY, 2016–2019 (MILLION UNITS)81TABLE 22APAC: HEARING AID DEVICES MARKET, BY COUNTRY, 2020–2026 (MILLION UNITS)82TABLE 23HEARING AID DEVICES MARKET, BY TYPE, 2016–2019 (USD MILLION)82TABLE 24HEARING AID DEVICES MARKET, BY TYPE, 2020–2026 (USD MILLION)83TABLE 25HEARING AID DEVICES MARKET, BY TYPE, 2016–2019 (MILLION UNITS)83TABLE 26HEARING AID DEVICES MARKET, BY TYPE, 2020–2026 (MILLION UNITS)836.2.1RECEIVER-IN-THE-EAR HEARING AIDS846.2.1.1RITE hearing aid devices are suitable for the treatment of mild-to-severe hearing loss84TABLE 27KEY PRODUCTS IN THE RECEIVER-IN-THE-EAR HEARING AIDS MARKET84TABLE 28RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION)85TABLE 29RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION)85TABLE 30EUROPE: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)86TABLE 31EUROPE: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)86TABLE 32NORTH AMERICA: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)87TABLE 33NORTH AMERICA: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)87TABLE 34APAC: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)87TABLE 35APAC: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)886.2.2BEHIND-THE-EAR HEARING AIDS886.2.2.1Low cost of BTE devices to support the market growth88TABLE 36KEY PRODUCTS IN THE BEHIND-THE-EAR HEARING AIDS MARKET89TABLE 37BEHIND-THE-EAR HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION)89TABLE 38BEHIND-THE-EAR HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION)90TABLE 39APAC: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)90TABLE 40APAC: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)91TABLE 41NORTH AMERICA: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)91TABLE 42NORTH AMERICA: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)91TABLE 43EUROPE: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)92TABLE 44EUROPE: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)926.2.3CANAL HEARING AIDS936.2.3.1Technological advancements in canal hearing aids to propel market growth93TABLE 45KEY PRODUCTS IN THE CANAL HEARING AIDS MARKET93TABLE 46CANAL HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION)94TABLE 47CANAL HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION)94TABLE 48NORTH AMERICA: CANAL HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)95TABLE 49NORTH AMERICA: CANAL HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)95TABLE 50EUROPE: CANAL HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)95TABLE 51EUROPE: CANAL HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)96TABLE 52APAC: CANAL HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)96TABLE 53APAC: CANAL HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)966.2.4IN-THE-EAR HEARING AIDS976.2.4.1Longer battery life of ITE hearing devices to support the market growth97TABLE 54IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION)97TABLE 55IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION)97TABLE 56EUROPE: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)98TABLE 57EUROPE: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)98TABLE 58APAC: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)99TABLE 59APAC: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)99TABLE 60NORTH AMERICA: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)99TABLE 61NORTH AMERICA: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)1006.2.5OTHER HEARING AID DEVICES100TABLE 62OTHER HEARING AID DEVICES MARKET, BY REGION, 2016–2019 (USD MILLION)100TABLE 63OTHER HEARING AID DEVICES MARKET, BY REGION, 2020–2026 (USD MILLION)101TABLE 64EUROPE: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2016–2019 (USD MILLION)101TABLE 65EUROPE: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2020–2026 (USD MILLION)102TABLE 66NORTH AMERICA: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2016–2019 (USD MILLION)102TABLE 67NORTH AMERICA: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2020–2026 (USD MILLION)102TABLE 68APAC: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2016–2019 (USD MILLION)103TABLE 69APAC: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2020–2026 (USD MILLION)1036.3HEARING IMPLANTS103TABLE 70HEARING IMPLANTS MARKET, BY REGION, 2016–2019 (USD MILLION)104TABLE 71HEARING IMPLANTS MARKET, BY REGION, 2020–2026 (USD MILLION)104TABLE 72EUROPE: HEARING IMPLANTS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)104TABLE 73EUROPE: HEARING IMPLANTS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)105TABLE 74NORTH AMERICA: HEARING IMPLANTS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)105TABLE 75NORTH AMERICA: HEARING IMPLANTS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)105TABLE 76APAC: HEARING IMPLANTS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)106TABLE 77APAC: HEARING IMPLANTS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)106TABLE 78HEARING IMPLANTS MARKET, BY TYPE, 2016–2019 (USD MILLION)106TABLE 79HEARING IMPLANTS MARKET, BY TYPE, 2020–2026 (USD MILLION)1076.3.1COCHLEAR IMPLANTS1076.3.1.1Cochlear implants segment to dominate the hearing implants market107TABLE 80KEY PRODUCTS IN THE COCHLEAR IMPLANTS MARKET108TABLE 81COCHLEAR IMPLANTS MARKET, BY REGION, 2016–2019 (USD MILLION)108TABLE 82COCHLEAR IMPLANTS MARKET, BY REGION, 2020–2026 (USD MILLION)108TABLE 83EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)109TABLE 84EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)109TABLE 85NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)109TABLE 86NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)110TABLE 87APAC: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)110TABLE 88APAC: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)1106.3.2BONE-ANCHORED SYSTEMS1116.3.2.1BAHA implants are gaining traction among children and adults with single-sided deafness and conductive hearing loss111TABLE 89BONE-ANCHORED SYSTEMS MARKET, BY REGION, 2016–2019 (USD MILLION)111TABLE 90BONE-ANCHORED SYSTEMS MARKET, BY REGION, 2020–2026 (USD MILLION)112TABLE 91EUROPE: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)112TABLE 92EUROPE: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)113TABLE 93NORTH AMERICA: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)113TABLE 94NORTH AMERICA: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)113TABLE 95APAC: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)114TABLE 96APAC: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)1147HEARING AIDS MARKET, BY TYPE OF HEARING LOSS1157.1INTRODUCTION116TABLE 97HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)116TABLE 98HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)1167.2SENSORINEURAL HEARING LOSS1167.2.1GROWING GERIATRIC PATIENT POOL TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT1167.2.1.1Primary notes1177.2.1.1.1Key industry insights117TABLE 99HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS, BY REGION, 2016–2019 (USD MILLION)118TABLE 100HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS, BY REGION, 2020–2026 (USD MILLION)1187.3CONDUCTIVE HEARING LOSS1187.3.1TECHNOLOGICAL ADVANCEMENTS IN HEARING AIDS AND INCREASING PRODUCT APPROVALS TO PROPEL MARKET GROWTH118TABLE 101HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS, BY REGION, 2016–2019 (USD MILLION)119TABLE 102HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS, BY REGION, 2020–2026 (USD MILLION)1198HEARING AIDS MARKET, BY PATIENT TYPE1208.1INTRODUCTION121TABLE 103HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)121TABLE 104HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)1218.2ADULTS1218.2.1HIGHER SUSCEPTIBILITY TO HEARING LOSS MAKES ADULTS A KEY SEGMENT OF THE OVERALL PATIENT POOL1218.2.1.1Primary notes1228.2.1.1.1Key industry insights122TABLE 105HEARING AIDS MARKET FOR ADULT PATIENTS, BY REGION, 2016–2019 (USD MILLION)123TABLE 106HEARING AIDS MARKET FOR ADULT PATIENTS, BY REGION, 2020–2026 (USD MILLION)1238.3PEDIATRICS1238.3.1TECHNOLOGICAL ADVANCEMENTS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT123TABLE 107HEARING AIDS MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2016–2019 (USD MILLION)124TABLE 108HEARING AIDS MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2020–2026 (USD MILLION)1259HEARING AIDS MARKET, BY REGION1269.1INTRODUCTION127TABLE 109HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION)127TABLE 110HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION)1279.2EUROPE128FIGURE 29EUROPE: HEARING AIDS MARKET SNAPSHOT128TABLE 111EUROPE: HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)129TABLE 112EUROPE: HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)129TABLE 113EUROPE: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)129TABLE 114EUROPE: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)130TABLE 115EUROPE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)130TABLE 116EUROPE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)1309.2.1GERMANY1319.2.1.1Growth in healthcare expenditure in Germany to drive the demand for technologically advanced hearing aids131FIGURE 30PREVALENCE OF HEARING LOSS IN GERMANY, 2015 VS. 2018131FIGURE 31ADOPTION RATE OF HEARING AIDS BY HEARING-IMPAIRED PEOPLE IN GERMANY, 2012 VS. 2015 VS. 2018131TABLE 117GERMANY: KEY MACROINDICATORS132TABLE 118GERMANY: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)132TABLE 119GERMANY: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)133TABLE 120GERMANY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)133TABLE 121GERMANY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)133TABLE 122GERMANY: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)134TABLE 123GERMANY: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)1349.2.2UK1349.2.2.1High and growing prevalence of hearing loss to drive market growth in the UK134TABLE 124UK: KEY MACROINDICATORS135TABLE 125UK: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)135TABLE 126UK: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)136TABLE 127UK: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)136TABLE 128UK: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)136TABLE 129UK: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)137TABLE 130UK: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)1379.2.3FRANCE1379.2.3.1Rising R&D expenditure in France to drive the market growth137FIGURE 32ADOPTION RATE OF HEARING AIDS BY HEARING-IMPAIRED PEOPLE IN FRANCE, 2012 VS. 2015 VS. 2018138TABLE 131FRANCE: KEY MACROINDICATORS138TABLE 132FRANCE: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)138TABLE 133FRANCE: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)139TABLE 134FRANCE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)139TABLE 135FRANCE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)139TABLE 136FRANCE: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)140TABLE 137FRANCE: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)1409.2.4SPAIN1409.2.4.1Increasing life expectancy and growing geriatric population to drive market growth in Spain140FIGURE 33SPAIN: PREVALENCE OF HEARING LOSS IN 2020, BY AGE GROUP141TABLE 138SPAIN: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)141TABLE 139SPAIN: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)142TABLE 140SPAIN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)142TABLE 141SPAIN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)142TABLE 142SPAIN: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)142TABLE 143SPAIN: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)1439.2.5ITALY1439.2.5.1Unfavorable reimbursement scenario to restrain market growth in Italy to a certain extent143FIGURE 34PREVALENCE OF HEARING LOSS IN ITALY, 2012 VS. 2015 VS. 2018143FIGURE 35HEARING AIDS ADOPTION RATE IN ITALY, 2012 VS. 2015 VS. 2018144TABLE 144ITALY: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)144TABLE 145ITALY: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)144TABLE 146ITALY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)145TABLE 147ITALY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)145TABLE 148ITALY: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)145TABLE 149ITALY: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)1469.2.6REST OF EUROPE146TABLE 150ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)146TABLE 151ROE: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)147TABLE 152ROE: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)147TABLE 153ROE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)147TABLE 154ROE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)148TABLE 155ROE: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)148TABLE 156ROE: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)1489.3NORTH AMERICA149TABLE 157NORTH AMERICA: HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)149TABLE 158NORTH AMERICA: HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)149TABLE 159NORTH AMERICA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)150TABLE 160NORTH AMERICA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)150TABLE 161NORTH AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)150TABLE 162NORTH AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)1519.3.1US1519.3.1.1The US dominated the North American hearing aids market in 2020151FIGURE 36NUMBER OF AUDIOLOGISTS IN THE US152TABLE 163US: KEY MACROINDICATORS153TABLE 164US: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)153TABLE 165US: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)153TABLE 166US: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)154TABLE 167US: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)154TABLE 168US: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)154TABLE 169US: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)1559.3.2CANADA1559.3.2.1Conferences, webinars, and symposia to provide impetus to the market growth155TABLE 170CANADA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)156TABLE 171CANADA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)156TABLE 172CANADA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)156TABLE 173CANADA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)157TABLE 174CANADA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)157TABLE 175CANADA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)1579.4ASIA PACIFIC158FIGURE 37ASIA PACIFIC: HEARING AIDS MARKET SNAPSHOT159TABLE 176APAC: HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)160TABLE 177APAC: HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)160TABLE 178APAC: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)160TABLE 179APAC: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)161TABLE 180APAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)161TABLE 181APAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)1619.4.1CHINA1619.4.1.1China dominated the APAC market for hearing aids in 2020161TABLE 182CHINA: KEY MACROINDICATORS162TABLE 183CHINA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)162TABLE 184CHINA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)162TABLE 185CHINA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)163TABLE 186CHINA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)163TABLE 187CHINA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)163TABLE 188CHINA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)1649.4.2INDIA1649.4.2.1Healthcare infrastructure improvements to drive market growth in India164TABLE 189INDIA: KEY MACROINDICATORS165TABLE 190INDIA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)165TABLE 191INDIA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)165TABLE 192INDIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)166TABLE 193INDIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)166TABLE 194INDIA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)166TABLE 195INDIA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)1679.4.3JAPAN1679.4.3.1Rising adoption of hearing aids in the country to support market growth167FIGURE 38HEARING AIDS ADOPTION RATE IN JAPAN, 2012 VS. 2015 VS. 2018167TABLE 196JAPAN: KEY MACROINDICATORS168TABLE 197JAPAN: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)168TABLE 198JAPAN: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)168TABLE 199JAPAN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)169TABLE 200JAPAN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)169TABLE 201JAPAN: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)169TABLE 202JAPAN: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)1709.4.4AUSTRALIA1709.4.4.1Rising geriatric population to drive market growth in Australia170FIGURE 39DISTRIBUTIVE SHARE OF POPULATION IN AUSTRALIA, BY AGE GROUP, 2016 VS. 2019170TABLE 203AUSTRALIA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)171TABLE 204AUSTRALIA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)171TABLE 205AUSTRALIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)172TABLE 206AUSTRALIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)172TABLE 207AUSTRALIA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)172TABLE 208AUSTRALIA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)1739.4.5REST OF ASIA PACIFIC173FIGURE 40DISTRIBUTIVE SHARE OF POPULATION IN TAIWAN, BY AGE GROUP, 2016 VS. 2019174TABLE 209ROAPAC: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)174TABLE 210ROAPAC: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)175TABLE 211ROAPAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)175TABLE 212ROAPAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)175TABLE 213ROAPAC: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)176TABLE 214ROAPAC: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)1769.5LATIN AMERICA1769.5.1INCREASING EFFORTS TO IMPLEMENT UNIVERSAL HEALTH COVERAGE IN THE REGION TO SUPPORT MARKET GROWTH176FIGURE 41NUMBER OF PEOPLE WITH DISABLING HEARING LOSS IN BRAZIL AND MEXICO, 2008 VS. 2018177TABLE 215LATIN AMERICA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)177TABLE 216LATIN AMERICA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)178TABLE 217LATIN AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)178TABLE 218LATIN AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)178TABLE 219LATIN AMERICA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)179TABLE 220LATIN AMERICA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)1799.6MIDDLE EAST & AFRICA1799.6.1HEALTHCARE INFRASTRUCTURE IMPROVEMENTS IN THE REGION TO DRIVE MARKET GROWTH179TABLE 221MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)180TABLE 222MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)180TABLE 223MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)180TABLE 224MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)181TABLE 225MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)181TABLE 226MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)18110COMPETITIVE LANDSCAPE18210.1OVERVIEW18210.2KEY PLAYER STRATEGIES/RIGHT TO WIN18210.2.1OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE HEARING AIDS MARKET183TABLE 227OVERVIEW OF STRATEGIES DEPLOYED BY KEY HEARING AIDS MANUFACTURING COMPANIES18310.3REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS184FIGURE 42REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE HEARING AIDS MARKET18410.4MARKET SHARE ANALYSIS185FIGURE 43HEARING AIDS MARKET SHARE, BY KEY PLAYER (2020)185TABLE 228HEARING AIDS MARKET: DEGREE OF COMPETITION18510.5COMPANY EVALUATION QUADRANT18610.5.1LIST OF EVALUATED VENDORS18610.5.2STARS18610.5.3EMERGING LEADERS18710.5.4PERVASIVE PLAYERS18710.5.5PARTICIPANTS187FIGURE 44HEARING AIDS MARKET: COMPETITIVE LEADERSHIP MAPPING, 202018810.6COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2020)18810.6.1PROGRESSIVE COMPANIES18810.6.2STARTING BLOCKS18910.6.3RESPONSIVE COMPANIES18910.6.4DYNAMIC COMPANIES189FIGURE 45HEARING AIDS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 202019010.7COMPETITIVE BENCHMARKING19010.7.1PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS190FIGURE 46PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE HEARING AIDS MARKET190TABLE 229PRODUCT FOOTPRINT OF COMPANIES191TABLE 230REGIONAL FOOTPRINT OF COMPANIES19110.8COMPETITIVE SCENARIO19210.8.1PRODUCT LAUNCHES & REGULATORY APPROVALS192TABLE 231KEY PRODUCT LAUNCHES & REGULATORY APPROVALS19210.8.2DEALS193TABLE 232KEY DEALS19311COMPANY PROFILES19411.1KEY PLAYERS194(Business Overview, Products Offered, Recent Developments, and MnM View)*11.1.1SONOVA GROUP194TABLE 233SONOVA GROUP: BUSINESS OVERVIEW194FIGURE 47SONOVA GROUP: COMPANY SNAPSHOT (2020)19511.1.2DEMANT A/S199TABLE 234DEMANT A/S: BUSINESS OVERVIEW199FIGURE 48DEMANT A/S: COMPANY SNAPSHOT (2020)20011.1.3GN STORE NORD A/S204TABLE 235GN STORE NORD A/S: BUSINESS OVERVIEW204FIGURE 49GN STORE NORD A/S: COMPANY SNAPSHOT (2020)20511.1.4COCHLEAR LTD.208TABLE 236COCHLEAR LTD.: BUSINESS OVERVIEW208FIGURE 50COCHLEAR LTD.: COMPANY SNAPSHOT (2020)20811.1.5RION CO., LTD.211TABLE 237RION CO., LTD.: BUSINESS OVERVIEW211FIGURE 51RION CO., LTD.: COMPANY SNAPSHOT (2020)21111.1.6STARKEY214TABLE 238STARKEY: BUSINESS OVERVIEW21411.1.7WS AUDIOLOGY A/S216TABLE 239WS AUDIOLOGY A/S: BUSINESS OVERVIEW21611.1.8NUROTRON BIOTECHNOLOGY CO., LTD.218TABLE 240NUROTRON BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW21811.1.9MED-EL219TABLE 241MED-EL: BUSINESS OVERVIEW21911.1.10AUDINA HEARING INSTRUMENTS, INC.220TABLE 242AUDINA HEARING INSTRUMENTS, INC.: BUSINESS OVERVIEW22011.1.11ELKON PVT. LTD.222TABLE 243ELKON PVT. LTD.: BUSINESS OVERVIEW222* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.11.2OTHER PLAYERS22311.2.1EARGO, INC.22311.2.2HORENTEK22411.2.3ZOUNDS HEARING INC.22511.2.4SEBOTEK HEARING SYSTEMS, LLC.22511.2.5ARPHI ELECTRONICS PRIVATE LIMITED22611.2.6IN4 TECHNOLOGY CORPORATION22711.2.7BHM-TECH PRODUKTIONSGESELLSCHAFT MBH22711.2.8NANO HEARING AIDS22811.2.9LORECA S.R.O.22911.2.10EARLENS CORPORATION23011.2.11AUSTAR HEARING SCIENCE AND TECHNOLOGY (XIAMEN) CO., LTD.23011.2.12LIVELY HEARING CORPORATION23011.2.13AUDIFON GMBH & CO. KG23111.2.14FOSHAN VOHOM TECHNOLOGY CO., LTD.23112APPENDIX23212.1DISCUSSION GUIDE23212.2KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL23512.3AVAILABLE CUSTOMIZATIONS23712.4RELATED REPORTS23712.5AUTHOR DETAILS238

お問合せフォーム

    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com

    医療・医薬の最新記事8件